Trial
NCT05724849
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
—
Condition
Head and Neck Cancer
Intervention
Venlafaxine
Why stopped
Issues with funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-18